Get started
Author

Helena Vanluchene

Observed name: Vanluchene, Helena
ORCID: 0000-0003-0118-2961
Observed ORCID: 0000-0003-0118-2961
OpenAlex ID: A5066444032
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
2021 · An-Katrien Minnaert, Helena Vanluchene, et al. · Advanced Drug Delivery Reviews · 156
PDF
ICG-mediated photodisruption of the inner limiting membrane enhances retinal drug delivery
2022 · Karen Peynshaert, Helena Vanluchene, et al. · Journal of Controlled Release · 33
Evaluation of size-exclusion chromatography, multi-angle light scattering detection and mass photometry for the characterization of mRNA
2024 · Jelle De Vos, Kris Morreel, et al. · Journal of Chromatography A · 30
Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye
2025 · Weiran Li, Helena Vanluchene, et al. · Journal of Controlled Release · 21
PDF
Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells
2024 · Helena Vanluchene, Oriane Gillon, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 19
PDF
Exploring the potential of oligonucleotide mapping with liquid chromatography – mass spectrometry to study the primary structure of mRNA
2025 · Jonathan Maurer, Helena Vanluchene, et al. · TrAC Trends in Analytical Chemistry · 13
A ribonucleic acid mapping brainteaser: solving a ribonuclease 4 / ribonuclease A crossword using pre- and post-column digestion
2026 · Kris Morreel, Helena Vanluchene, et al. · Journal of Chromatography A · 2
Works count: 8
Citation count: 274
H-index: 6
I10-index: 6
Year
Topic
Type